Acolyte Biomedica  

The world of Microbiology 

Acolyte Biomedica Limited is a privately-funded UK company developing proprietary diagnostic systems for clinical microbiology.  Acolyte’s technology (‘BacLiteTM’) allows microbial detection and antibiotic sensitivity determination in 2-5 hours instead of days, reducing hospital costs and improving management of infectious disease patients. BacLite technology is unique within infectious disease diagnostics, providing antibiotic susceptibility testing (AST) and micro-organism detection direct from clinical specimens.  

    

BacLite technology was originally developed by the Defence Science & Technology Laboratory (Dstl) at Porton Down, a division of The UK Ministry of Defence.  It exploits the bioluminescent detection of Adenylate Kinase (AK) for ultrasensitive antibiotic susceptibility and micro-organism detection.  Acolyte has the exclusive license to BacLite for clinical microbiology and benefits from an ongoing collaboration with Dstl, which is also a shareholder in Acolyte.